Follow
Heather M Long
Heather M Long
Associate Professor, University of Birmingham
Verified email at bham.ac.uk
Title
Cited by
Cited by
Year
Guidelines for the use of flow cytometry and cell sorting in immunological studies
A Cossarizza, HD Chang, A Radbruch, A Acs, D Adam, S Adam‐Klages, ...
European journal of immunology 49 (10), 1457-1973, 2019
17392019
The immunology of Epstein-Barr virus–induced disease
GS Taylor, HM Long, JM Brooks, AB Rickinson, AD Hislop
Annual review of immunology 33, 787-821, 2015
5572015
CXCR5+ follicular cytotoxic T cells control viral infection in B cell follicles
YA Leong, Y Chen, HS Ong, D Wu, K Man, C Deleage, M Minnich, ...
Nature immunology 17 (10), 1187-1196, 2016
4482016
Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection
J Zuo, AC Dowell, H Pearce, K Verma, HM Long, J Begum, F Aiano, ...
Nature immunology 22 (5), 620-626, 2021
4132021
An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 link
GL Kelly, HM Long, J Stylianou, WA Thomas, A Leese, AI Bell, ...
PLoS pathogens 5 (3), e1000341, 2009
2072009
CD4+ T-cell responses to Epstein-Barr virus (EBV) latent-cycle antigens and the recognition of EBV-transformed lymphoblastoid cell lines
HM Long, TA Haigh, NH Gudgeon, AM Leen, CW Tsang, J Brooks, ...
Journal of virology 79 (8), 4896-4907, 2005
1802005
Cellular immune controls over Epstein–Barr virus infection: new lessons from the clinic and the laboratory
AB Rickinson, HM Long, U Palendira, C Münz, AD Hislop
Trends in immunology 35 (4), 159-169, 2014
1572014
MHC II tetramers visualize human CD4+ T cell responses to Epstein–Barr virus infection and demonstrate atypical kinetics of the nuclear antigen EBNA1 response
HM Long, OL Chagoury, AM Leese, GB Ryan, E James, LT Morton, ...
Journal of Experimental Medicine 210 (5), 933-949, 2013
1302013
Immune defence against EBV and EBV-associated disease
HM Long, GS Taylor, AB Rickinson
Current opinion in immunology 23 (2), 258-264, 2011
1222011
Cytotoxic CD4+ T cell responses to EBV contrast with CD8 responses in breadth of lytic cycle antigen choice and in lytic cycle recognition
HM Long, AM Leese, OL Chagoury, SR Connerty, J Quarcoopome, ...
The Journal of Immunology 187 (1), 92-101, 2011
1022011
Early virological and immunological events in asymptomatic Epstein-Barr virus infection in African children
S Jayasooriya, TI De Silva, J Njie-jobe, C Sanyang, AM Leese, AI Bell, ...
PLoS pathogens 11 (3), e1004746, 2015
1012015
The T-cell response to Epstein-Barr virus–new tricks from an old dog
HM Long, BJ Meckiff, GS Taylor
Frontiers in immunology 10, 483952, 2019
902019
A role for intercellular antigen transfer in the recognition of EBV-transformed B cell lines by EBV nuclear antigen-specific CD4+ T cells
GS Taylor, HM Long, TA Haigh, M Larsen, J Brooks, AB Rickinson
The Journal of Immunology 177 (6), 3746-3756, 2006
882006
Epstein-Barr Virus Evades CD4+ T Cell Responses in Lytic Cycle through BZLF1-mediated Downregulation of CD74 and the Cooperation of vBcl-2
J Zuo, WA Thomas, TA Haigh, L Fitzsimmons, HM Long, AD Hislop, ...
PLoS pathogens 7 (12), e1002455, 2011
872011
A novel latent membrane 2 transcript expressed in Epstein-Barr virus–positive NK-and T-cell lymphoproliferative disease encodes a target for cellular immunotherapy
CP Fox, TA Haigh, GS Taylor, HM Long, SP Lee, C Shannon-Lowe, ...
Blood, The Journal of the American Society of Hematology 116 (19), 3695-3704, 2010
842010
Asymptomatic primary infection with Epstein-Barr virus: observations on young adult cases
RJ Abbott, A Pachnio, I Pedroza-Pacheco, AM Leese, J Begum, HM Long, ...
Journal of Virology 91 (21), 10.1128/jvi. 00382-17, 2017
802017
Early T cell recognition of B cells following Epstein-Barr virus infection: identifying potential targets for prophylactic vaccination
JM Brooks, HM Long, RJ Tierney, C Shannon-Lowe, AM Leese, ...
PLoS pathogens 12 (4), e1005549, 2016
552016
Regression of Epstein-Barr virus-induced B-cell transformation in vitro involves virus-specific CD8+ T cells as the principal effectors and a novel CD4+ T-cell reactivity
NH Gudgeon, GS Taylor, HM Long, TA Haigh, AB Rickinson
Journal of virology 79 (9), 5477-5488, 2005
552005
Recruitment mechanisms of primary and malignant B cells to the human liver
S Shetty, T Bruns, CJ Weston, Z Stamataki, YH Oo, HM Long, ...
Hepatology 56 (4), 1521-1531, 2012
532012
Primary EBV infection induces an acute wave of activated antigen-specific cytotoxic CD4+ T cells
BJ Meckiff, K Ladell, JE McLaren, GB Ryan, AM Leese, EA James, ...
The Journal of Immunology 203 (5), 1276-1287, 2019
512019
The system can't perform the operation now. Try again later.
Articles 1–20